Skip to main
UNH

UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group (UNH) Analyst Ratings

Based on 25 analyst ratings
Buy
Strong Buy 24%
Buy 56%
Hold 12%
Sell 8%
Strong Sell 0%

Bulls say

UnitedHealth Group is a highly attractive investment given its massive scale in the healthcare industry, along with its strong leadership position in employer-sponsored, self-directed, and government-backed insurance plans. The company's Optum franchises also contribute to its success and are expected to generate significant earnings in the future, especially in the second half of 2026. Despite potential risks, such as regulatory and reimbursement challenges, the company's strong financials, impactful AI investments, and strategic initiatives make it a compelling buy opportunity for investors.

Bears say

UnitedHealth Group is a dominant player in the health insurance industry, with its massive scale and diversified business lines. Despite its recent earnings beat and guidance raise, there are risks related to its high exposure to government programs and potential regulatory challenges. Overall, based on its current valuation and potential risks, UnitedHealth Group's stock outlook is negative.

UnitedHealth Group (UNH) has been analyzed by 25 analysts, with a consensus rating of Buy. 24% of analysts recommend a Strong Buy, 56% recommend Buy, 12% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of UnitedHealth Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About UnitedHealth Group (UNH) Forecast

Analysts have given UnitedHealth Group (UNH) a Buy based on their latest research and market trends.

According to 25 analysts, UnitedHealth Group (UNH) has a Buy consensus rating as of May 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $378.64, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $378.64, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

UnitedHealth Group (UNH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.